Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jonathan G Pol, Julien Rességuier & Brian D Lichty. (2012) Oncolytic viruses: a step into cancer immunotherapy. Virus Adaptation and Treatment 4, pages 1-21.
Read now
Read now
Keith A. Lawson & Don G. Morris. (2012) Oncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?. Expert Opinion on Biological Therapy 12:7, pages 891-903.
Read now
Read now
Jun Li, Xinsheng Huang, Xiaofeng Xie, Jianzhong Wang & Maoli Duan. (2011) Human telomerase reverse transcriptase regulates cyclin D1 and G1/S phase transition in laryngeal squamous carcinoma. Acta Oto-Laryngologica 131:5, pages 546-551.
Read now
Read now
Dong-Sheng Pei, Jie-Hui Di, Fei-Fei Chen & Jun-Nian Zheng. (2010) Oncolytic-adenovirus-expressed RNA interference for cancer therapy. Expert Opinion on Biological Therapy 10:9, pages 1331-1341.
Read now
Read now
Shou-Li Wang, Hui-Hua Yao & Zheng-Hong Qin. (2009) Strategies for short hairpin RNA delivery in cancer gene therapy. Expert Opinion on Biological Therapy 9:11, pages 1357-1368.
Read now
Read now
Articles from other publishers (15)
Suneela Pyreddy, Arpita Poddar, Francesco Carraro, Shakil Ahmed Polash, Chaitali Dekiwadia, Billy Murdoch, Zeyad Nasa, T. Srinivasa Reddy, Paolo Falcaro & Ravi Shukla. (2023) Targeting telomerase utilizing zeolitic imidazole frameworks as non-viral gene delivery agents across different cancer cell types. Biomaterials Advances 149, pages 213420.
Crossref
Crossref
Christie Vermeulen, Tereza Brachtlova, Nikki Tol, Ida H. van der Meulen-Muileman, Jasmina Hodzic, Henri J. van de Vrugt & Victor W. van Beusechem. (2022) Evaluation of a Novel Oncolytic Adenovirus Silencing SYVN1. International Journal of Molecular Sciences 23:23, pages 15430.
Crossref
Crossref
Tereza Brachtlova, Jan-Willem van Ginkel, Mark J. Luinenburg, Renée X. de Menezes, Danijela Koppers-Lalic, D. Michiel Pegtel, Wenliang Dong, Tanja D. de Gruijl & Victor W. van Beusechem. (2020) Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format. Molecular Therapy - Oncolytics 19, pages 332-343.
Crossref
Crossref
Francesco Carrozza, Matteo Santoni, Francesco Piva, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Rodolfo Montironi, Nicola Battelli & Stefano Tamberi. (2018) Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors. Critical Reviews in Oncology/Hematology 131, pages 1-6.
Crossref
Crossref
Ahmad Rahal & Benjamin Musher. (2017) Oncolytic viral therapy for pancreatic cancer. Journal of Surgical Oncology 116:1, pages 94-103.
Crossref
Crossref
Jie Zhang, Meng Ding, Kai Xu, Lijun Mao & Junian Zheng. (2016) shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy. Oncotarget 7:20, pages 29824-29834.
Crossref
Crossref
A?elya Yilmazer, Bowen Tian & Kostas Kostarelos. (2014) Development of Dual-Activity Vectors by Co-Envelopment of Adenovirus and SiRNA in Artificial Lipid Bilayers. PLoS ONE 9:12, pages e114985.
Crossref
Crossref
XIN-JUN CHEN, KAI ZHANG, YONG XIN & GUAN JIANG. (2014) Oncolytic adenovirus-expressed RNA interference of O6-methylguanine DNA methyltransferase activity may enhance the antitumor effects of temozolomide. Oncology Letters 8:5, pages 2201-2202.
Crossref
Crossref
Guan Jiang, Ai-Jun Jiang, Yong Xin, Lian-Tao Li, Qian Cheng & Jun-Nian Zheng. (2014) Progression of O6-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research. Molecular Biology Reports 41:10, pages 6659-6665.
Crossref
Crossref
Dong zhi Qiang, Jing Bo Shi, Bao An Song & Xin Hua Liu. (2014) Novel 2H-chromen derivatives: design, synthesis and anticancer activity. RSC Advances 4:11, pages 5607.
Crossref
Crossref
WENXUAN ZHANG & LINA XING. (2013) RNAi gene therapy of SiHa cells via targeting human TERT induces growth inhibition and enhances radiosensitivity. International Journal of Oncology 43:4, pages 1228-1234.
Crossref
Crossref
Henry Fechner & Jens Kurreck. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology
1415
1442
.
Xiqiang Liu, Hongzhang Huang, Jianguang Wang, Cheng Wang, Miao Wang, Bin Zhang & Chaobin Pan. (2011) Dendrimers-delivered short hairpin RNA targeting hTERT inhibits oral cancer cell growth in vitro and in vivo. Biochemical Pharmacology 82:1, pages 17-23.
Crossref
Crossref
Xueling Ren, Yue Ma, Min Xu, Tingting Chen, Zhenzhong Zhang & Yun Zhang. (2011) Construction, modification and evaluation of apolipoprotein A-I promoter-driven shRNA expression vectors against hTERT. Plasmid 65:1, pages 42-50.
Crossref
Crossref
Guan Jiang, Yan-Qun Liu, Zhi-Ping Wei, Dong-Sheng Pei, Li-Jun Mao & Jun-Nian Zheng. (2010) Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. Cancer Letters 294:2, pages 220-228.
Crossref
Crossref